RALTEGRAVIR AND ENFUVIRTIDE AS A “BRIDGE” ANTIRETROVIRAL THERAPY IN KIDNEY-TRANSPLANTED PATIENTS WITH HIV INFECTION RECEIVING AN EVEROLIMUS-BASED REGIMEN: A STUDY ON OUTCOMES AND DRUG INTERACTIONS.: 2273